BCRX: BioCryst O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
GURU.Markets terminalidagi PEG koeffitsiyenti talab dinamikasini namoyish etadi, bunda 0.00 komponentlar yetkazib berishdagi geosiyosiy uzilishlarning ta'siri ostidagi metrikaning joriy hajmini ko'rsatadi. BioCryst samaradorligi robotlashtirilgan inhibitor skriningiga asoslangan, bozoridagi mavqe barqarorligi esa orfan dori vositalarining murakkab sintezi va FDA patent himoyasi bilan ta'minlanadi.
BioCryst (BCRX) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati BioCryst|BCRX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi biocryst.com|BCRX - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar BioCryst Pharmaceuticals Inc|BCRX - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzi BioCryst|Oraliq qoplama koeffitsiyenti biocryst.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
BCRX - Kompaniyaning sof foydasi|Kutilayotgan sof foyda BioCryst|BCRX - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati BioCryst Corp|BCRX - Narxning foydaga va o‘sish sur’atiga nisbati|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati BioCryst Pharmaceuticals Inc|BCRX - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda BioCryst|BCRX - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi biocryst.com|BCRX - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning prognoz qilingan ortishi BioCryst
Kompaniyaning umumiy tahlili:BCRX - BioCryst Pharmaceuticals, Inc.
PEG koeffitsiyenti joriy P/E ko'paytirgichini foyda o'sishi bilan solishtiradi va bu bozor narxining biznes kengayish sur'atiga nisbatan adolatli ekanligini aniqlash imkonini beradi. P/E-o'sish grafigini tahlil qilish orqali investor aktivning qadrsizlanganligi belgisi sifatida birdan pastki qiymatlarni qidiradi, bu esa BioCryst (BCRX) uchun shishga qarshi dori vositasining sotuv samaradorligini va yangi mahsulot liniyalariga sarflangan xarajatlarga qaramay operatsion modelning barqarorligini tasdiqlaydi.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori VERA (Vera Therapeutics)|Dianthus Therapeutics Inc (DNTH) - O‘sish sur’atiga tuzatilgan narx-foyda|Pharvaris Corp - PEG multiplikatori|ABCL: Narxning foydaga va o‘sish sur’atiga nisbati|TRML: PEG multiplikatori|PGEN - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Pharming Group|O‘sish sur’atiga tuzatilgan narx-foyda Nektar Therapeutics Inc NKTR|PEG multiplikatori UPB|Narx-foyda va o‘sish multiplikatori Zenas Corp ZBIO|Narxning foydaga va o‘sish sur’atiga nisbati Immunome, Inc. IMNM|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti GOSS|KALV: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Septerna, Inc.|Pieris Pharmaceuticals Inc (PVLA) - Narxning foydaga va o‘sish sur’atiga nisbati|SVRA - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori RIGL|ANAB (anaptysbio.com) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori ATXS|Narxning foydaga va o‘sish sur’atiga nisbati ENGN (enGene Holdings Inc)|PEG multiplikatori RAPT (RAPT Therapeutics, Inc.)|JBIO - Narx-foyda va o‘sish multiplikatori|ACRS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti KYTX (kyvernatx.com)|TLSA (Tiziana Life Sciences Ltd) - Narx-foyda va o‘sish multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti CABA|Narxning foydaga va o‘sish sur’atiga nisbati Ventyx Bio|Theratechnologies, Inc - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori AVTX|ELDN (eledon.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori AGEN (Agenus Inc.)|PEG multiplikatori Climb Bio Inc. CLYM|ZURA - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ATYR (aTyr Pharmaceuticals)|adagene.com (ADAG) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Ikena Oncology|STTK (Shattuck Labs Inc) - PEG multiplikatori|PEG multiplikatori Equillium Bio|Narx-foyda va o‘sish multiplikatori CNTB (Connect Biopharma)|IMUX (immunic-therapeutics.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ATRA (Atara Bio)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati InflaRx NV (IFRX)|XFOR - Narxning foydaga va o‘sish sur’atiga nisbati|Adicet Bio (ACET) - Narx-foyda va o‘sish multiplikatori|celularity.com (CELU) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori INmune Bio Corporation|Narx-foyda va o‘sish multiplikatori BRNS|PEG multiplikatori kezarlifesciences.com|Narxning foydaga va o‘sish sur’atiga nisbati SAB Biotherapeutics, Inc. (SABS)|Akari Therapeutics PLC - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori ENLV (Enlivex Therapeutics Ltd.)|Q32 Bio Inc (QTTB) - O‘sish sur’atiga tuzatilgan narx-foyda|GeoVax Labs, Inc. - PEG multiplikatori|EDSA: Narxning foydaga va o‘sish sur’atiga nisbati|IBIO: PEG multiplikatori|CARM - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati XTL Biopharmaceuticals, Ltd.|O‘sish sur’atiga tuzatilgan narx-foyda Bolt Bio BOLT|PEG multiplikatori HCWB|Narx-foyda va o‘sish multiplikatori aptevotherapeutics.com APVO|Narxning foydaga va o‘sish sur’atiga nisbati AIM ImmunoTech AIM|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ADTX|GRI: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda XORTX Corp|Vyome Holdings Inc (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|REVB - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori INDP|SCNI (Scinai Immunotherapeutics Ltd) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori CALI|Narxning foydaga va o‘sish sur’atiga nisbati AFMD (affimed.com)|PEG multiplikatori ALLK (Allakos)|HOOK - Narx-foyda va o‘sish multiplikatori|IGMS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ITOS (iTeos Therapeutics Inc)|OCEA (Ocean Bio) - Narx-foyda va o‘sish multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti TCBP|Narxning foydaga va o‘sish sur’atiga nisbati Third Harmonic Bio
